Random word

On this page you'll find 10+ example sentences with Neurocrine. Discover the meaning, how to use the word correctly in a sentence.

Rare word

Neurocrine in a sentence

Neurocrine meaning

Describing a paracrine hormone released from neuronal cells

Using Neurocrine

  • The main meaning on this page is: Describing a paracrine hormone released from neuronal cells
  • In the example corpus, neurocrine often appears in combinations such as: neurocrine biosciences, of neurocrine, in neurocrine.

Context around Neurocrine

  • Average sentence length in these examples: 20.9 words
  • Position in the sentence: 3 start, 17 middle, 0 end
  • Sentence types: 20 statements, 0 questions, 0 exclamations

Corpus analysis for Neurocrine

  • In this selection, "neurocrine" usually appears in the middle of the sentence. The average example has 20.9 words, and this corpus slice is mostly made up of statements.
  • Around the word, raised, marketbeat and biosciences stand out and add context to how "neurocrine" is used.
  • Recognizable usage signals include holdings in neurocrine biosciences by and shares of neurocrine biosciences in. That gives this page its own corpus information beyond isolated example sentences.
  • By corpus frequency, "neurocrine" sits close to words such as abattoirs, aberrant and abike, which helps place it inside the broader word index.

Example types with neurocrine

The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:

Brown Advisory Inc. increased its holdings in Neurocrine Biosciences by 0.5% in the 3rd quarter. (16 words)

These ratings convey expectations for the relative performance of Neurocrine Biosciences compared to the broader market. (16 words)

Vanguard Group Inc. boosted its position in Neurocrine Biosciences by 2.3% during the first quarter. (16 words)

Dupont Capital Management Corp reduced its stake in shares of Neurocrine Biosciences, Inc. () by 15.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). (35 words)

The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through William H. Rastetter sold 903 shares of Neurocrine Biosciences stock in a transaction dated Wednesday, April 19th. (34 words)

Wedbush reissued an “outperform” rating and issued a $152.00 target price on shares of Neurocrine Biosciences in a research note on Wednesday, May 29th. (25 words)

Example sentences (20)

Alberta Investment Management Corp raised its holdings in Neurocrine Biosciences by 10.4% during the 2nd quarter.

As a group, analysts anticipate that Neurocrine Biosciences, Inc. will post 2.17 EPS for the current year.

As a group, sell-side analysts predict that Neurocrine Biosciences will post 2.2 EPS for the current fiscal year.

Brown Advisory Inc. increased its holdings in Neurocrine Biosciences by 0.5% in the 3rd quarter.

Cantor Fitzgerald reaffirmed an “overweight” rating and set a $136.00 price objective on shares of Neurocrine Biosciences in a research note on Tuesday.

Congress Asset Management Co. MA raised its holdings in Neurocrine Biosciences by 1.9% in the third quarter.

Dupont Capital Management Corp reduced its stake in shares of Neurocrine Biosciences, Inc. () by 15.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).

Finally, raised Neurocrine Biosciences from a buy rating to a strong-buy rating in a report on Thursday, December 7th.

Advertentie

HC Wainwright reaffirmed a “buy” rating and set a $140.00 price objective on shares of Neurocrine Biosciences in a research note on Tuesday.

Neurocrine Biosciences had a net margin of 4.19% and a return on equity of 4.06%.

The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through William H. Rastetter sold 903 shares of Neurocrine Biosciences stock in a transaction dated Wednesday, April 19th.

According to data from MarketBeat, Neurocrine Biosciences presently has an average rating of “Moderate Buy” and an average target price of $137.

Advisors Asset Management Inc.’s holdings in Neurocrine Biosciences were worth $2,444,000 as of its most recent filing with the SEC.

Finally, Balentine LLC boosted its holdings in shares of Neurocrine Biosciences by 4.0% during the 4th quarter.

KB Financial Partners LLC purchased a new position in Neurocrine Biosciences in the first quarter worth about $32,000.

Mercer Global Advisors Inc. ADV grew its stake in Neurocrine Biosciences by 29.9% in the fourth quarter.

Renaissance Technologies LLC boosted its position in shares of Neurocrine Biosciences by 9.6% during the 2nd quarter.

These ratings convey expectations for the relative performance of Neurocrine Biosciences compared to the broader market.

Vanguard Group Inc. boosted its position in Neurocrine Biosciences by 2.3% during the first quarter.

Wedbush reissued an “outperform” rating and issued a $152.00 target price on shares of Neurocrine Biosciences in a research note on Wednesday, May 29th.

Advertentie

Common combinations with neurocrine

These word pairs occur most frequently in English texts:

Frequently asked questions

How do you use "neurocrine" in a sentence?
An example: "Alberta Investment Management Corp raised its holdings in Neurocrine Biosciences by 10.4% during the 2nd quarter." This page contains 10+ example sentences with the word "neurocrine" from authentic English texts.
What does "neurocrine" mean?
Neurocrine means: Describing a paracrine hormone released from neuronal cells
How many example sentences with "neurocrine" are there?
Voorbeeldzinnen.info contains at least 10+ example sentences with "neurocrine", drawn from a database of millions of English sentences.